Mangalam Drugs (India) Investor Sentiment

MANGALAM   79.79  0.32  0.40%   
About 61% of Mangalam Drugs' investor base is looking to short. The analysis of overall sentiment of trading Mangalam Drugs And stock suggests that many investors are alarmed at this time. The current market sentiment, together with Mangalam Drugs' historical and current headlines, can help investors time the market. In addition, many technical investors use Mangalam Drugs And stock news signals to limit their universe of possible portfolio assets.
  
over two weeks ago at news.google.com         
Stock market update Nifty Bank index falls 0.48 percent - MSN
Google News at Macroaxis
over two weeks ago at news.google.com         
Mangalam Drugs Consolidated December 2024 Net Sales at Rs 88.71 crore, down 8.86 percent Y-o-Y - Mon...
Google News at Macroaxis
over a month ago at news.google.com         
Mangalam Drugs Organics Third Quarter 2025 Earnings EPS 0.81 - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
Mangalam Drugs Faces Debt Challenges Despite Consistent Profit Growth and Sales Increase - MarketsMo...
Google News at Macroaxis
over a month ago at news.google.com         
Mangalam Drugs Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended...
Google News at Macroaxis
over a month ago at news.google.com         
Mangalam Drugs Reports Q2 FY24-25 Profit Amid Debt Servicing Challenges - MarketsMojo
Google News at Macroaxis
over two months ago at news.google.com         
Mangalam Drugs Reports Rs 5.37 Crore PAT in Q2 FY24-25 Amid Downgrade to Hold - MarketsMojo
Google News at Macroaxis
over two months ago at news.google.com         
Mangalam Drugs and Organics Reports Rs 5.37 Crore PAT, Receives Buy Rating Upgrade - MarketsMojo
Google News at Macroaxis
over three months ago at news.google.com         
Par Drugs Chemicals Ltd Experiences Revision in Stock Evaluation Amid Strong Market Performance - Ma...
Google News at Macroaxis
over three months ago at news.google.com         
Mangalam Drugs and Organics Ltd leads gainers in B group - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Mangalam Drugs Standalone September 2024 Net Sales at Rs 79.94 crore, down 1.98 percent Y-o-Y - Mone...
Google News at Macroaxis
over three months ago at news.google.com         
Additional Considerations Required While Assessing Mangalam Drugs Organics Strong Earnings - Simply ...
Google News at Macroaxis
over three months ago at news.google.com         
Mangalam Drugs and Organics Shows Strong Financial Growth, Surpasses Previous Years PAT in Just Half...
Google News at Macroaxis
over three months ago at news.google.com         
Are Mangalam Drugs Organics Limiteds Mixed Financials The Reason For Its Gloomy Performance on The S...
Google News at Macroaxis
over six months ago at news.google.com         
Mangalam Drugs receives 274,800 grant for Malaria drug research - BusinessLine
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Mangalam Drugs that are available to investors today. That information is available publicly through Mangalam media outlets and privately through word of mouth or via Mangalam internal channels. However, regardless of the origin, that massive amount of Mangalam data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Mangalam Drugs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mangalam Drugs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mangalam Drugs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mangalam Drugs alpha.

Mangalam Drugs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Mangalam Drugs Reports Rs 5.37 Crore PAT in Q2 FY24-25 Amid Downgrade to Hold - MarketsMojo
01/07/2025
2
Mangalam Drugs Faces Debt Challenges Despite Consistent Profit Growth and Sales Increase - MarketsMojo
02/14/2025
3
Stock market update Nifty Bank index falls 0.48 percent - MSN
03/04/2025

Complementary Tools for Mangalam Stock analysis

When running Mangalam Drugs' price analysis, check to measure Mangalam Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangalam Drugs is operating at the current time. Most of Mangalam Drugs' value examination focuses on studying past and present price action to predict the probability of Mangalam Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangalam Drugs' price. Additionally, you may evaluate how the addition of Mangalam Drugs to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance